Journal Home
Search for

Volume 53, Issue 4, Pages 617-627 (April 2009)


View previous. 8 of 266 View next.

Sodium Bicarbonate Therapy for Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis

Sankar D. Navaneethan, MD, MPH1Corresponding Author Informationemail address, Sonal Singh, MD, MPH2, Suresh Appasamy, MD3, Richard E. Wing, MD4, Ashwini R. Sehgal, MD5

Received 24 April 2008; accepted 27 August 2008. published online 25 November 2008.

Background

Optimal hydration measures to prevent contrast-induced nephropathy are controversial.

Study Design

We conducted a systematic review and meta-analysis using the MEDLINE database (1966 to January 2008), EMBASE (January 2008), and abstracts from conference proceedings.

Setting & Population

Adult patients undergoing contrast procedures.

Selection Criteria for Studies

Randomized controlled trials comparing intravenous hydration with sodium bicarbonate with hydration with intravenous normal saline for prevention of contrast-induced nephropathy.

Intervention

Hydration with intravenous sodium bicarbonate with or without N-acetylcysteine versus hydration with normal saline with or without N-acetylcysteine.

Outcomes

Contrast-induced nephropathy, need for renal replacement therapy, and worsening of heart failure.

Results

Twelve trials (1,854 participants) were included. Sodium bicarbonate significantly decreased the risk of contrast-induced nephropathy (12 trials, 1,652 patients; odds ratio [OR], 0.46; 95% confidence interval [CI], 0.26 to 0.82; I2 = 55.9%) without a significant difference in need for renal replacement therapy (9 trials, 1,215 patients; OR, 0.50; 95% CI, 0.16 to 1.53; I2 = 0%), in-hospital mortality (11 trials, 1,640 patients; OR, 0.51; 95% CI, 0.15 to 1.69), or congestive heart failure compared with controls. Similar results were seen for the risk of contrast-induced nephropathy when sodium bicarbonate was compared with normal saline alone (OR, 0.39; 95% CI, 0.20 to 0.77), but not when sodium bicarbonate/N-acetylcysteine combination was compared with N-acetylcysteine/normal saline combination (OR, 0.68; 95% CI, 0.34 to 1.37). A subgroup analysis limited to published trials showed similar results (OR, 0.26; 95% CI, 0.10 to 0.64; I2 = 63.3%), whereas unpublished studies showed a nonsignificant decrease (OR, 0.85; 95% CI, 0.46 to 1.57; I2 = 25.9%) in risk of contrast-induced nephropathy.

Limitation

Publication bias and heterogeneity.

Conclusion

Hydration with sodium bicarbonate decreases the incidence of contrast-induced nephropathy in comparison to hydration with normal saline without a significant difference in need for renal replacement therapy and in-hospital mortality. Larger studies analyzing patient-centered outcomes are needed.

1 Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, OH

2 Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC

3 Department of Medicine, New York Downtown Hospital, New York

4 Nephrology Unit, University of Rochester School of Medicine and Dentistry, Rochester, NY

5 Division of Nephrology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH

Corresponding Author InformationAddress correspondence to Sankar D. Navaneethan, MD, MPH, Department of Nephrology and Hypertension, Cleveland Clinic, 9500 Euclid Ave, A51, Cleveland, OH 44195

 Originally published online as doi:10.1053/j.ajkd.2008.08.033 on November 25, 2008.

PII: S0272-6386(08)01431-5

doi:10.1053/j.ajkd.2008.08.033


View previous. 8 of 266 View next.